The American Journal of Managed Care1h
Case Series Shows Possible Link Between Semaglutide, Ophthalmic Complications
Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...
News Medical16h
Weekly diabetes injection could replace daily shots for lipodystrophy patients
Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...
Rutgers University19h
A Weekly Injection Could Replace Painful Daily Treatment for Rare Fat Disorder
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
Eli Lilly & Co. Receives Buy Rating from David Risinger Due to Promising Tirzepatide Trial Results and Competitive Tolerability
Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...
Lexaria Bioscience price target lowered to $7 from $10 at H.C. Wainwright
H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Lexaria Bioscience (LEXX) to $7 from $10 and keeps a Buy rating on the ...